Tokura Taichiro

トクラタイチロウ | Tokura Taichiro

Affiliation and department：
Papers (5)：

Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori, et al. Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study. Asia-Pacific journal of clinical oncology. 2023. 19. 1. 136-148
Ryu Matsunaga, Yoshikazu Kanazawa, Kunihiko Matsuno, Daisuke Kakinuma, Taichiro Tokura, Atsushi Marumo, Shunsuke Yui, Fumihiko Ando, Yuka Masuda, Nobutoshi Hagiwara, et al. An advanced case of gastric histiocytic sarcoma treated with chemotherapy and gastrectomy: a case report and review of literature. Clinical journal of gastroenterology. 2021. 14. 4. 1053-1059
Yusuke Fujiwara, Hiroki Yamaguchi, Shunsuke Yui, Taichiro Tokura, Kazuki Inai, Daishi Onai, Ikuko Omori, Atsushi Marumo, Satoshi Yamanaka, Masahiro Sakaguchi, et al. Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia. International journal of laboratory hematology. 2019. 41. 4. 461-471
Kazuki Terada, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Yutaka Kobayashi, Kenji Tajika, Seiji Gomi, Saiko Kurosawa, Riho Saito, Yutaka Furuta, et al. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis. Genes, chromosomes & cancer. 2018. 57. 8. 401-408
Kazuki Terada, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Yutaka Kobayashi, Kenji Tajika, Seiji Gomi, Saiko Kurosawa, Keiki Miyadera, Taichiro Tokura, et al. Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor. Annals of hematology. 2018. 97. 1. 51-61

Lectures and oral presentations (14)：

A case of septic cardiomyopathy rapidly developed from Salmonella colitis during maintenance therapy for multiple myeloma, requiring intensive treatment with IABP
(The 98th Annual Meeting of the Japanese Association for Infectious Diseases/The 72nd Annual Meeting of the Japanese Society of Chemotherapy 2024)
Myelodysplastic syndrome treated with hematopoietic stem cell transplantation after prophylactic colectomy to prevent recurrence of repeated diverticulitis
(The 46th Annual Meeting of the Japanese Society for Transplantation and Cellular Therapy 2024)
A successful case of tirabrutinib suspension for DLBCL brain relapse with coma and Cushing reflex
(The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology 2024)
A successful case of chemoradiotherapy for pyothorax-associated lymphoma (PAL) arising from chronic empyema after left total pneumonectomy
(The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology 2024)
The clinical features and prognostic impact of acute myeloid leukemia with KMT2A gene abnormalities
(The 85th Congress of the Japanese Society of Hematology 2023)

ｍore...

Education (3)：

2022 - 現在 Nippon Medical School Postgraduate School Hematology
2022 - 2024 University of Massachusetts Master’s Degree
2011 - 2017 Nippon Medical School Bachelor of Medicine

Professional career (1)：

Master's Degree (University of Massachusetts)

Work history (11)：

2024/04 - 現在 Tokyo Metropolitan Tama-Hokubu Medical Center Hematology
2022/10 - 2024/03 Yokohama Minami Kyosai Hospital Hematology
2022/04 - 2022/09 Nippon Medical School Hospital Hematology Assistant Professor
2021/10 - 2022/03 Nippon Medical School Hospital Hematology
2020/10 - 2021/09 Yokohama Minami Kyosai Hospital Hematology

Show all

Awards (3)：

2023/10 - The 85th Congress of the Japanese Society of Hematology Best Poster Award The clinical features and prognostic impact of acute myeloid leukemia with KMT2A gene abnormalities
2020/09 - The 4th Regional Meeting of The Japanese Society of Intensive Care Medicine Young Best Presentation Award Successful treatment and diagnosis of myxedema coma secondary to sepsis in a patient with acute lymphoblastic leukemia: A case report
2019/07 - The 52th Meeting of the Society for Geriatric Hematology Special Award Clinical outcomes of R-THP-COP as first-line chemotherapy in patients with DLBCL aged 80 years and older

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page